17β-Hydroxysteroid Dehydrogenase-2 Deficiency and Progesterone Resistance in Endometriosis
review
OA: green
CC0
⤵ 56 in-corpus citations
Abstract
Estradiol (E2) stimulates the growth and inflammation in the ectopic endometriotic tissue that commonly resides on the pelvic organs. Several clinical and laboratory-based observations are indicative of resistance to progesterone action in endometriosis. The molecular basis of progesterone resistance in endometriosis may be related to an overall reduction in the levels of progesterone receptor (PR). In normal endometrium, progesterone acts via PR on stromal cells to induce secretion of paracrine factor(s) that in turn stimulate neighboring epithelial cells to express the enzyme 17beta-hydroxysteroid dehydrogenase type 2 (HSD17B2). HSD17B2 is an extremely efficient enzyme and rapidly metabolizes the biologically potent estrogen E2 to weakly estrogenic estrone. In endometriotic tissue, progesterone is incapable of inducing epithelial HSD17B2 expression due to a defect in stromal cells. The inability of endometriotic stromal cells to produce progesterone-induced paracrine factors that stimulate HSD17B2 may be due to the very low levels of PR observed in vivo in endometriotic tissue. The end result is deficient metabolism of E2 in endometriosis giving rise to high local concentrations of this mitogen. The molecular details of this physiological paracrine interaction between the stroma and epithelium in normal endometrium and its lack thereof in endometriosis are discussed.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (33)
- Deficient 17β-Hydroxysteroid Dehydrogenase Type 2 Expression in Endometriosis: Failure to Metabolize 17β-Estradiol<sup>1</sup> via openalex
- Estrogen and progesterone receptors in endometriotic tissue and endometrium: comparison according to localization and recurrence. via openalex
- Expression Profiling of Endometrium from Women with Endometriosis Reveals Candidate Genes for Disease-Based Implantation Failure and Infertility via openalex
- Gene Expression Analysis of Endometrium Reveals Progesterone Resistance and Candidate Susceptibility Genes in Women with Endometriosis via openalex
- Ovarian steroid receptor expression in endometriosis and in two potential parent epithelia: endometrium and peritoneal mesothelium via openalex
- Progesterone Receptor Isoform A But Not B Is Expressed in Endometriosis via openalex
- Progestins for symptomatic endometriosis: a critical analysis of the evidence via openalex
- Steroidal regulation of endometriosis tissue: lack of induction of 17β-hydroxysteroid dehydrogenase activity by progesterone, medroxyprogesterone acetate, or danazol via openalex
- Stromal cells of endometriosis fail to produce paracrine factors that induce epithelial 17β-hydroxysteroid dehydrogenase type 2 gene and its transcriptional regulator Sp1: a mechanism for defective estradiol metabolism via openalex
- W2012313039 via openalex
- W2025995094 via openalex
- W2026079978 via openalex
- W2041320907 via openalex
- W2044526252 via openalex
- W2047249984 via openalex
- W2050194681 via openalex
- W2050770488 via openalex
- W2052777384 via openalex
- W2053311013 via openalex
- W2077644752 via openalex
- W2084167766 via openalex
- W2152628855 via openalex
- W2274786089 via openalex
- W151949596 via openalex
- W4290386699 via openalex
- W1525342509 via openalex
- W1569704074 via openalex
- W1969489572 via openalex
- W1972931629 via openalex
- W1977482986 via openalex
- W1978601816 via openalex
- W1984784419 via openalex
- W2010311608 via openalex
Cited by (50)
- The Microbiota–Endometriosis Axis: An Immune–Endocrine Integration Model and Emerging Therapeutic Targets 2026
- Effect of high-intensity focused ultrasound ablation on lesion stiffness and symptoms of adenomyosis 2026
- Etiologies of endometriosis and model systems: is there a risk of a tunnel vision? 2025
- Leveraging epigenetic aberrations in the pathogenesis of endometriosis: from DNA methylation to non-coding RNAs 2025
- TGF-β/snail-mediated epithelial-to-mesenchymal transition disrupts estradiol metabolism through suppressing the HSD17B2 expression in endometriotic epithelial cells 2025
- Endometriotic lesions express microRNAs that potentially regulate the transcription of hydroxysteroid 17-beta dehydrogenase 2 (HSD17B2): a pilot study 2024
- Biological characteristics related to treatment effects of the levonorgestrel-releasing intrauterine system on adenomyosis-associated dysmenorrhoea 2024
- Gene expression of aromatase, SF-1, and HSD17B2 in menstrual blood as noninvasive diagnostic biomarkers for endometriosis 2024
- Overview of crosstalk between stromal and epithelial cells in the pathogenesis of adenomyosis and shared features with deep endometriotic nodules 2024
- PREGNANCY COMPLICATIONS IN PATIENTS WITH ENDOMETRIOSIS 2023
- High mobility group box 1 promotes endometriosis under hypoxia by regulating inflammation and autophagy in vitro and in vivo 2023
- An irreversible inhibitor of 17β-hydroxysteroid dehydrogenase type 1 inhibits estradiol synthesis in human endometriosis lesions and induces regression of the non-human primate endometriosis 2022
- Obstetric and perinatal outcomes in women with endometriosis 2022
- Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis 2022
- Faculty Opinions recommendation of Polyphenols as a Diet Therapy Concept for Endometriosis-Current Opinion and Future Perspectives. 2021
- Pharmacological Management of Endometriosis-related Pain: The Expert Opinion 2021
- Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review 2021
- Effects of dual inhibition of AKT and ERK1/2 pathways on endometrial pro-inflammatory, hormonal, and epigenetic microenvironment in endometriosis 2021
- Polyphenols as a Diet Therapy Concept for Endometriosis—Current Opinion and Future Perspectives 2021
- Endometriosis, infertility and MicroRNA's: A review 2021
- Predictors of illness acceptance in women with endometriosis 2020
- 90 YEARS OF PROGESTERONE: Selective progesterone receptor modulators in gynaecological therapies 2020
- The Role of the Glucocorticoid Receptor Signalling Pathway within the Human Endometrium 2019
- Differential expression of progesterone receptor isoforms related to PGR +331g/a polymorphism in endometriosis: A case-control study 2019
- Loss of HDAC3 results in nonreceptive endometrium and female infertility 2019
- Bufalin suppresses endometriosis progression by inducing pyroptosis and apoptosis 2018
- Pathogenesis of endometriosis: the genetic/epigenetic theory 2018
- SULFATION PATHWAYS: Contribution of intracrine oestrogens to the aetiology of endometriosis 2018
- Treatment of Endometriosis-Related Chronic Pelvic Pain with Ulipristal Acetate and Associated Endometrial Changes 2017
- Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills 2017
- Endometrial stromal cell attachment and matrix homeostasis in abdominal wall endometriomas 2017
- Retinoid Metabolism in Endometriosis 2017
- Research Priorities for Endometriosis: Recommendations From a Global Consortium of Investigators in Endometriosis 2016
- The estrogen metabolites 2-methoxyestradiol and 2-hydroxyestradiol inhibit endometriotic cell proliferation in estrogen-receptor-independent manner 2016
- Effects of a Levonorgestrel-Releasing Intrauterine System on the Expression of Steroid Receptor Coregulators in Adenomyosis 2015
- Bentamapimod (JNK Inhibitor AS602801) Induces Regression of Endometriotic Lesions in Animal Models 2015
- The dynamics of nuclear receptors and nuclear receptor coregulators in the pathogenesis of endometriosis 2014
- Potential role of aromatase inhibitors in the treatment of endometriosis 2014
- Etiopatogenia da Endometriose 2013
- Endometriosis: a life cycle approach? 2013
- Obstacles And Pitfalls Of Endometriosis-Related Chronic Pelvic Pain Management: Trying To Alleviate The Burden 2013
- Interplay between Misplaced Müllerian-Derived Stem Cells and Peritoneal Immune Dysregulation in the Pathogenesis of Endometriosis 2013
- Expression of the G protein-coupled estrogen receptor (GPER) in endometriosis: a tissue microarray study 2012
- Endométriose : pourquoi se développe-telle ? 2012
- Progesterone Resistance and Targeting the Progesterone Receptors: A Therapeutic Approach to Endometriosis 2012
- Aromatase inhibitors for the treatment of endometriosis 2012
- HDAC1 and HDAC2 are differentially expressed in endometriosis 2012
- Tissue Remodeling and Nonendometrium-Like Menstrual Cycling Are Hallmarks of Peritoneal Endometriosis Lesions 2012
- Inhibition of steroid sulfatase decreases endometriosis in an in vivo murine model 2011
- Signaling Pathways in Endometriosis (Eutopic/Ectopic) 2011
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:17:18.915199+00:00
License: CC0
· commercial use OK